Analysts, rejoice. Metys® offers predefined dashboards for quick answers and a powerful report builder for custom views – plus Excel integration for seamless workflows. It’s market intelligence, your way. Explore Mety...
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
What ICER Pricing Would Mean for U.S. Drug Spend
The Institute for Clinical and Economic Review (ICER) is a major force in payer–manufacturer price negotiations. In a 2018 ICON plc survey of more than 20 U.S. payers, more than three quarters of respondents said that they would use an ICER cost-effectiveness threshold as a basis for negotiating a rebate contract. Read more from ICON's Nathan White, Adam Johns, and Eric Latch in the September 2018 issue of Managed Care.
-
CROs Must Be Aware Of Threat Posed By Big Tech
ICON’s CEO Steve Cutler discusses the impact of biotech funding and disruptive tech providers in this Scrip article.
-
The Path To A Successful Digital Trial
Transforming Clinical Trials: The Path To A Successful Digital Trial. A Thought Leadership article in Scrip Pharma Intelligence by Marie Mc Carthy, Senior Director Product Innovation, ICON and Chen Admati, Head of Intel Pharma Analytics Platform, Intel.
-
Adaptive Designs: Smarter Development Programmes for Oncology
A thought leadership article by Parvin Fardipour and Alan Phillips in Pharmafocus, which reviews the different types of adaptive trial designs that have been deployed in oncology trials to good effect, and discusses how they have changed the development paradigm.
-
Stakeholder Dialogue in Europe’s Adaptive Pathways Pilot
Get insights on the how the 3 principles of EMA’s adaptive pathways have worked in practice and what to expect for future accelerated access in Europe in this Pharmaceutical Market Europe (PME) edition.
-
Challenges in Clinical Trials
Steve Cutler, outlines some of the challenges to successful clinical trials in this PharmaTimes artice.
-
Device Certification and Recertification
ICON experts Vicki Anastasi and Karen Hill outline a three-step approach in this MD+DI article to identify products with the highest commercial value, helping you prioritize your medical and IVD devices for compliance with the new MDR and IVDR.
-
Evaluation of Psoriasis Patient Attitudes in their Choice of Treatments
Psoriasis patients’ prior treatment history impacts future treatment choices. ICON’s Lina Eliasson contributes to this article.
-
Outsourcing Evolution
A thought leadership article in the International Clinical Trials by Colin Stanley on the broad spectrum of outsourcing models being deployed in the pharmaceutical industry, in particular discussing the role of Functional Service Provision (FSP) approach.
-
Four Challenges Under the New EU MDR and IVDR
This Medical Plastics News (MPN) Article authored by Vicki Anastasi and Karen Hill examines the key challenges associated with the new EU Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR).
